<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04018976</url>
  </required_header>
  <id_info>
    <org_study_id>AVACENOGTT</org_study_id>
    <nct_id>NCT04018976</nct_id>
  </id_info>
  <brief_title>AVACEN Treatment Method and Postprandial Blood Glucose</brief_title>
  <official_title>AVACEN Treatment Method and Postprandial Blood Glucose</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>San Diego State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>San Diego State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A double-blind crossover randomized controlled trial to investigate the effects of the AVACEN
      device on postprandial blood glucose. The AVACEN device creates negative pressure around the
      hand while heating the palm. Two sham devices, one providing heat but no vacuum and one
      providing neither heat nor vacuum were also used. Each subject will use each of these three
      devices during the first hour of a 2-hour oral glucose tolerance test on separate visits.
      Subjects arrived in the morning following an overnight fast. Fasting blood glucose, blood
      pressure, tympanic temperature, and subjective thermal ratings were measured before and
      throughout the 2-hour oral glucose tolerance test.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 5, 2019</start_date>
  <completion_date type="Actual">September 15, 2019</completion_date>
  <primary_completion_date type="Actual">September 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postprandial Blood Glucose</measure>
    <time_frame>30 minutes</time_frame>
    <description>Measuring peak postprandial blood glucose with Contour Next glucometer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>30 minutes</time_frame>
    <description>Measuring blood pressure with automated cuff</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tympanic Temperature</measure>
    <time_frame>30 minutes</time_frame>
    <description>Measuring tympanic temperature with infrared thermometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ASHRAE 7 point thermal sensation scale</measure>
    <time_frame>30 minutes</time_frame>
    <description>Measuring subjective temperature with thermal sensation scale</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Postprandial Hyperglycemia</condition>
  <arm_group>
    <arm_group_label>Heat and Vacuum</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>AVACEN 100 applies heat and vacuum to hand</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Heat Only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>AVACEN 100 applies heat only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>AVACEN 100 applies neither heat nor vacuum</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AVACEN 100</intervention_name>
    <description>The AVACEN 100 pulls a -30mmHg vacuum around the hand from the wrist down and applies heat (108 Fahrenheit) to the palm</description>
    <arm_group_label>Heat and Vacuum</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AVACEN 100 heat only</intervention_name>
    <description>The AVACEN 100 applies heat (108 Fahrenheit) to the palm</description>
    <arm_group_label>Heat Only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AVACEN 100 sham</intervention_name>
    <description>The AVACEN 100 does not provide heat or vacuum</description>
    <arm_group_label>Sham</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy individuals

        Exclusion Criteria:

          -  Diagnosis of diabetes, diabetes medication, hypertension medication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeff M Moore, B.S./B.S.</last_name>
    <role>Principal Investigator</role>
    <affiliation>San Diego State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jeff Moore</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92182</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>July 6, 2019</study_first_submitted>
  <study_first_submitted_qc>July 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 15, 2019</study_first_posted>
  <last_update_submitted>October 26, 2019</last_update_submitted>
  <last_update_submitted_qc>October 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>San Diego State University</investigator_affiliation>
    <investigator_full_name>Jeff Moore</investigator_full_name>
    <investigator_title>Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

